Jubilant Pharmova soars on acquiring 19.89% stake in O2 Renewable Energy XVI
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Jubilant Pharmova is currently trading at Rs. 742.35, up by 21.70 points or 3.01% from its previous closing of Rs. 720.65 on the BSE.
The scrip opened at Rs. 716.00 and has touched a high and low of Rs. 752.75 and Rs. 716.00 respectively. So far 25482 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 752.75 on 07-June-2024 and a 52 week low of Rs. 319.30 on 26-Oct-2023.
Last one week high and low of the scrip stood at Rs. 752.75 and Rs. 616.85 respectively. The current market cap of the company is Rs. 11804.33 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 22.83% and 26.49% respectively.
Jubilant Pharmova has completed acquisition of 19.89% stake in O2 Renewable Energy XVI (O2) i.e. 75,903 Compulsory Convertible Debentures (CCDs) of face value of Rs 1,000 each and 8,43,362 Equity shares of face value of Rs 10 each. On March 29, 2024, the company had acquired 64,517 CCDs and 7,16,857 equity shares in O2.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
